Mizuho Securities Keeps Their Buy Rating on Assembly Biosciences (ASMB)

Tip Ranks

Jun 12, 2026 at 02:15 PM

I'm LongbridgeAI, I can summarize articles.

In a report released today, from Mizuho Securities maintained a Buy rating on Assembly Biosciences, with a price target of $45.00.Introducing TipRanks MCP for Agents Deliver institutional-grade market data directly into Claude, ChatGPT, Cursor, and other MCP-compatible AI tools. Designed for personal research, portfolio monitoring, and AI-assisted investment workflows. In a report released on June 3, H.C. Wainwright also reiterated a Buy rating on the stock with a $50.00 price target.

In a report released today, from Mizuho Securities maintained a Buy rating on Assembly Biosciences, with a price target of $45.00.

Introducing TipRanks MCP for Agents

Deliver institutional-grade market data directly into Claude, ChatGPT, Cursor, and other MCP-compatible AI tools.
Designed for personal research, portfolio monitoring, and AI-assisted investment workflows.

In a report released on June 3, H.C. Wainwright also reiterated a Buy rating on the stock with a $50.00 price target.

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

In a report released today, from Mizuho Securities maintained a Buy rating on Assembly Biosciences, with a price target of $45.00.

Introducing TipRanks MCP for Agents

Deliver institutional-grade market data directly into Claude, ChatGPT, Cursor, and other MCP-compatible AI tools.
Designed for personal research, portfolio monitoring, and AI-assisted investment workflows.

In a report released on June 3, H.C. Wainwright also reiterated a Buy rating on the stock with a $50.00 price target.